BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14962242)

  • 21. [Topical steroid injection for refractory oral chronic graft-versus-host disease].
    Ohbayashi Y; Imataki O; Higuchi A; Miyake M; Ohue Y; Ohnishi H
    Rinsho Ketsueki; 2007 Nov; 48(11):1508-10. PubMed ID: 18080511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lichenoid chronic graft-vs-host disease.
    Reisfeld PL
    Arch Dermatol; 1994 Sep; 130(9):1207-8. PubMed ID: 8085882
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic graft versus host disease.
    Higman MA; Vogelsang GB
    Br J Haematol; 2004 May; 125(4):435-54. PubMed ID: 15142114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Graft-versus-host disease].
    Vázquez Sell L
    Rev Clin Esp; 1986 Sep; 179(4):165-6. PubMed ID: 3764003
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic graft-versus-host disease revealed by lichenoid vulvar lesions successfully treated with thalidomide.
    Staumont-Sallé D; Magro L; Piette F; Thomas P; Jouet JP; Catteau B
    Acta Derm Venereol; 2003; 83(4):302-3. PubMed ID: 12926809
    [No Abstract]   [Full Text] [Related]  

  • 26. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells.
    Trzonkowski P; Bieniaszewska M; Juścińska J; Dobyszuk A; Krzystyniak A; Marek N; Myśliwska J; Hellmann A
    Clin Immunol; 2009 Oct; 133(1):22-6. PubMed ID: 19559653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients.
    Pereira CM; de Almeida OP; Correa ME; Souza CA; Barjas-Castro ML
    Gen Dent; 2007; 55(1):48-51. PubMed ID: 17333967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tissue regeneration and immunosuppression by mesenchymal stem cells].
    Lorenz HM; Ho AD
    Dtsch Med Wochenschr; 2006 Apr; 131(16):892-5. PubMed ID: 16625484
    [No Abstract]   [Full Text] [Related]  

  • 29. Ancillary and supportive care in chronic graft-versus-host disease.
    Couriel DR
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):291-307. PubMed ID: 18503994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linear lichenoid graft-vs-host disease.
    Wilson BB; Lockman DW
    Arch Dermatol; 1994 Sep; 130(9):1206-8. PubMed ID: 8085881
    [No Abstract]   [Full Text] [Related]  

  • 31. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
    Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
    Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.
    Albert MH; Becker B; Schuster FR; Klein B; Binder V; Adam K; Nienhoff C; Führer M; Borkhardt A
    Pediatr Transplant; 2007 May; 11(3):306-11. PubMed ID: 17430488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells.
    Fang B; Song YP; Liao LM; Han Q; Zhao RC
    Bone Marrow Transplant; 2006 Sep; 38(5):389-90. PubMed ID: 16878145
    [No Abstract]   [Full Text] [Related]  

  • 35. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
    Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
    J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter to the editor. Mucoceles.
    Resende RG; Correia-Silva Jde F; de Almeida HC; Vaz RR; Gomez RS
    Spec Care Dentist; 2010; 30(3):127-8. PubMed ID: 20500709
    [No Abstract]   [Full Text] [Related]  

  • 37. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
    Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
    J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on ocular graft versus host disease.
    Kim SK
    Curr Opin Ophthalmol; 2006 Aug; 17(4):344-8. PubMed ID: 16900025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent superficial mucoceles associated with lichenoid disorders.
    Campana F; Sibaud V; Chauvel A; Boiron JM; Taieb A; Fricain JC
    J Oral Maxillofac Surg; 2006 Dec; 64(12):1830-3. PubMed ID: 17113455
    [No Abstract]   [Full Text] [Related]  

  • 40. [Graft rejections and their treatments].
    Remiszewski P; Wiatr E
    Pneumonol Alergol Pol; 2005; 73(1):94-9. PubMed ID: 16539191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.